SMTL ID : 8ztx.1

Crystal Structure of Human Myt1 Kinase domain Bounded with compound 6b

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x 01: 2-azanyl-3-(2,6-dimethyl-3-oxidanyl-phenyl)-5-pyridin-4-yl-benzamide

01.1: 17 residues within 4Å: Chain A: L.42, G.43, Y.47, V.50, A.63, V.64, K.65, H.87, V.97, T.113, E.114, L.115, C.116, G.117, F.166, G.176, D.177 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.50, A:A.63, A:K.65, A:T.113, A:F.166, A:F.166 Hydrogen bonds: A:T.113, A:E.114, A:C.116, A:C.116, A:D.177, A:F.178 Water bridges: A:H.87

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, C. et al., Structure-Based Drug Design of 2-Amino-[1,1'-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1 -Amplified Breast Cancer. J.Med.Chem. (2024)

Release Date

2024-09-11

Peptides

Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase